Similar articles

• Radiotherapy combined with ICRF 159 (NSC 129943).

  Rhomberg WU. Rhomberg WU. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8. Int J Radiat Oncol Biol Phys. 1978. PMID: 204615 No abstract available.
• A clinical evaluation of ICRF 159 as a radiosensitising agent.

  Bates T. Bates T. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):127-31. doi: 10.1016/0360-3016(78)90127-x. Int J Radiat Oncol Biol Phys. 1978. PMID: 344288 Clinical Trial. No abstract available.
• [Clinical experiences with radiotherapy and ICRF 159 in sarcomas].

  Rhomberg W, Mesche E, Gefeller D, Hassenstein E. Rhomberg W, et al. Strahlentherapie Sonderb. 1978;75:110-4. Strahlentherapie Sonderb. 1978. PMID: 400195 Clinical Trial. German. No abstract available.
• Radiation as a therapeutic modality in sarcomas of the soft tissue.

  Suit H, Spiro I. Suit H, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):733-46. Hematol Oncol Clin North Am. 1995. PMID: 7490238 Review.
• Chemoradiation treatment strategies for localized sarcoma: conventional and investigational approaches.

  Pisters PW. Pisters PW. Semin Surg Oncol. 1999 Jul-Aug;17(1):66-71. doi: 10.1002/(sici)1098-2388(199907/08)17:1<66::aid-ssu8>3.0.co;2-2. Semin Surg Oncol. 1999. PMID: 10402639 Review.